Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 181, Issue 2, Pages 275-285
Publisher
Wiley
Online
2015-01-22
DOI
10.1111/cei.12593
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Anti-HIV Antibody-Dependent Activation of NK Cells Impairs NKp46 Expression
- (2013) M. S. Parsons et al. JOURNAL OF IMMUNOLOGY
- The search for an HIV cure: tackling latent infection
- (2013) Stephen J Kent et al. LANCET INFECTIOUS DISEASES
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune control of HIV-1 reservoirs
- (2013) Brigitte Autran et al. Current Opinion in HIV and AIDS
- Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression
- (2012) M. Jia et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection
- (2012) Leia H. Wren et al. IMMUNOLOGY
- Virologically Suppressed HIV Patients Show Activation of NK Cells and Persistent Innate Immune Activation
- (2012) G. F. Lichtfuss et al. JOURNAL OF IMMUNOLOGY
- Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
- (2012) D. C. Montefiori et al. JOURNAL OF INFECTIOUS DISEASES
- HIV Infection Abrogates the Functional Advantage of Natural Killer Cells Educated through KIR3DL1/HLA-Bw4 Interactions To Mediate Anti-HIV Antibody-Dependent Cellular Cytotoxicity
- (2012) Matthew S. Parsons et al. JOURNAL OF VIROLOGY
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge
- (2012) Michael D. Alpert et al. PLoS Pathogens
- HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads
- (2012) Jennifer Mabuka et al. PLoS Pathogens
- Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells
- (2010) Matthew S. Parsons et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection
- (2009) Salix Boulet et al. AIDS
- Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals
- (2009) Salix Boulet et al. AIDS
- Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers
- (2009) Olivier Lambotte et al. AIDS
- Regulation of human NK-cell cytokine and chemokine production by target cell recognition
- (2009) C. Fauriat et al. BLOOD
- Matrix Metalloprotease Inhibitors Restore Impaired NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Human Immunodeficiency Virus Type 1 Infection
- (2009) Q. Liu et al. JOURNAL OF VIROLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started